Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Ovarian Neoplasms 14 Lung Neoplasms 12 Melanoma 11 Colorectal Neoplasms 9 Breast Neoplasms 9 Stomach Neoplasms 7 Pancreatic Neoplasms 7 Triple Negative Breast Neoplasms 6 Neoplasms 6 Neoplasm Metastasis 6 Mesothelioma 6 Carcinoma, Merkel Cell 5 Small Cell Lung Carcinoma 4 Multiple Myeloma 4 Mesothelioma, Malignant 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Urogenital Neoplasms 3 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Squamous Cell 3 Thymoma 2

Interventions

Carboplatin 71 Paclitaxel 49 Radiotherapy 44 Pemetrexed 42 Cisplatin 41 Bevacizumab 39 Gemcitabine 27 Docetaxel 27 Erlotinib Hydrochloride 23 Gefitinib 18 pembrolizumab 14 Taxes 13 Vinorelbine 10 Cetuximab 10 Radiation 8 Nivolumab 8 Magnetic Resonance Spectroscopy 8 capmatinib 7 Radiosurgery 7 Platinum 7 Etoposide 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 Mastectomy, Segmental 6 ceritinib 5 aflutinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Cyclophosphamide 5 Biopsy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × fludarabine × Thoracic × Clear all

NCT05566223 2026-02-23

CheckCell-2

Intima Bioscience, Inc.

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡